CoverMyMeds
Overcoming barriers to medication access and affordability for patients throughout every step of their journey.
Biopharma Capabilities
Advancing Healthcare Forward
The biopharma landscape has never been more complex or more promising. We help navigate every stage of research and development, including engaging diverse populations in clinical trials and enabling patient access to prescribed therapies.
For us, Advancing Health Outcomes for All® means helping biopharma companies of all sizes bridge the divide between today’s challenges and tomorrow’s breakthrough therapies. Whether we’re delivering an evidence plan with real-world and clinical trial data, helping match patients to clinical trials or designing data and analytics solutions, we support our partners’ clinical development needs. Additionally, we accelerate the commercialization of therapies through distribution, specialty pharmacy and third-party logistics and enable patient access and affordability. Beyond our solutions, we also work to shape healthcare policies, helping advance patient outcomes and our partners’ success.
The True Meaning of Partnership
With a common purpose of Advancing Health Outcomes for All®, we work with our biopharma partners to deliver innovative medicines and therapies to patients.
At the heart of these trusted partnerships — built on expertise, collaboration and data-driven insights — we work together to navigate complexity and accelerate innovation to ultimately improve patients’ access to the care they need.
Our Businesses
Providing access, affordability, insights and technology services
McKesson Compile
Helping biopharma companies develop and commercialize life-changing therapies through premier data and analytics solutions.
Supporting oncology and specialty therapy innovation
The US Oncology Network
Bringing cancer care close to home.
Ontada
Accelerating life science research and provider channels to enable engagement and insights.
Sarah Cannon Research Institute
Advancing the field of cancer research together.
Biologics by McKesson
Delivering personalized care as an independent specialty pharmacy.
InspiroGene by McKesson
Solving the complexities of cell and gene therapies.
Genospace
Innovating precision medicine to improve patient outcomes by enabling clinical trial matching.
Offering logistics support and educational resources
McKesson Medical-Surgical
Delivering therapies and lab products accurately, safely, securely and on time.
Clinical Research Services and Clinical Trial Solutions
Supporting the commercialization of medications by simplifying clinical trial logistics.
McKesson Product Awareness Services
Providing pharmacy awareness and education programs.
McKesson Third Party Logistics®
Ensuring the lifesaving therapies arrive safely, efficiently and on time.
McKesson Group Purchasing Strategies
Maximizing contract savings for specialty practices.
Our Distribution Services
Our top-tier pharmaceutical distribution and logistics solutions are designed with our partners and their patients in mind. We partner with biopharma companies of all sizes to distribute new and established therapies accurately, safely, securely and on time. Additionally, we handle a wide range of product types and therapeutic areas, including specialty medications, branded drugs, cell and gene therapies, plasma products and generics.
Biopharma Capabilities at a Glance
Biopharma companies work in many different ways to advance clinical innovations, product launches and continued growth. That’s why we tailor solutions to meet our partners’ needs by leveraging a deep bench of therapeutic expertise, extensive networks of data and cutting-edge technologies.
$8.8B+
We saved patients more than $8.8 billion in out-of-pocket costs through CoverMyMeds.1
300M+
At McKesson Compile, our data follows more than 300 million patients throughout their health journey.
20k+
We’ve supported phase I - IV clinical trials that have helped over 20,000 patients.
10.7M
Through CoverMyMeds, we’ve helped save nearly 10.7 million prescriptions from abandonment.1
3.1k+
At SCRI, we enroll more than 3,100 patients in our cancer clinical trials each year.
1.4M+
We treat more than 1.4 million patients each year through The US Oncology Network.
10+
We have 10+ years of experience supporting cell and gene therapy programs.
First-Ever
We provided real-world evidence for the first-ever FDA-approved Metastatic Merkel Cell Carcinoma drug.
Our Focus Areas
From clinical development to commercialization, our biopharma partners can leverage our expertise at any stage of their process.
Serving as strategic advisors
Identifying and solving complex problems
Accelerating development
Harnessing widespread data for insights and analytics
Optimizing and de-risking launch capabilities
Who We Serve
We advance health outcomes for all by helping our partners bridge the divide between today’s challenges and tomorrow’s breakthroughs so more patients can get the care they need.
Manufacturing Companies
Biopharma Companies
Biotech Companies
Life Sciences Companies
Pharmaceutical Companies
News & Stories
Explore Our Biopharma Insights and Resources
Bridging Innovation and Access
McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC
McKesson’s Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
Expanding Access to Cell and Gene Therapy for Patients
InspiroGene by McKesson Partners with Vertex to Expand Distribution Options for CASGEVY® (exagamglogene autotemcel)
Ontada Collaborates with Datavant to Enable Faster Access to Market-Leading Oncology Insights
Ontada Collaborates with Microsoft to Transform Unstructured Oncology Data with Azure OpenAI Technology
InspiroGene by McKesson Unveils First-of-its-Kind Report on State of the Cell and Gene Therapy Landscape, Revealing Unparalleled Optimism Amidst Complex Challenges
McKesson Launches InspiroGene, a Dedicated Business to Guide and Support the Commercialization of Cell and Gene Therapies
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures
Hope in Action
Need to reach someone?
1 Based on CoverMyMeds affordability solution data for calendar year 2023